Herbalife Ltd (NYSE:HLF – Get Free Report) insider Frank Lamberti sold 134,982 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $13.50, for a total value of $1,822,257.00. Following the completion of the sale, the insider owned 36,624 shares in the company, valued at $494,424. This represents a 78.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Frank Lamberti also recently made the following trade(s):
- On Monday, May 11th, Frank Lamberti sold 7,937 shares of Herbalife stock. The shares were sold at an average price of $13.86, for a total value of $110,006.82.
Herbalife Stock Down 4.5%
NYSE:HLF opened at $13.02 on Thursday. The stock’s 50 day moving average price is $15.46 and its two-hundred day moving average price is $14.41. The firm has a market capitalization of $1.35 billion, a price-to-earnings ratio of 5.71, a P/E/G ratio of 0.81 and a beta of 0.98. Herbalife Ltd has a 12-month low of $6.62 and a 12-month high of $20.40.
Hedge Funds Weigh In On Herbalife
Hedge funds have recently added to or reduced their stakes in the stock. Optimize Financial Inc bought a new position in Herbalife during the 3rd quarter worth $511,000. Iridian Asset Management LLC CT increased its stake in Herbalife by 9.9% during the 3rd quarter. Iridian Asset Management LLC CT now owns 2,449,155 shares of the company’s stock worth $20,671,000 after acquiring an additional 220,896 shares during the period. GSA Capital Partners LLP bought a new position in Herbalife during the 3rd quarter worth $911,000. CenterBook Partners LP bought a new position in Herbalife during the 3rd quarter worth $368,000. Finally, Picton Mahoney Asset Management bought a new position in Herbalife during the 3rd quarter worth $898,000.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on the company. Wall Street Zen upgraded Herbalife from a “buy” rating to a “strong-buy” rating in a research note on Saturday, April 18th. Zacks Research lowered Herbalife from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Citigroup reiterated a “buy” rating and set a $21.00 target price (up from $17.00) on shares of Herbalife in a research note on Thursday, February 19th. Royal Bank Of Canada lowered their target price on Herbalife from $17.00 to $16.00 and set a “sector perform” rating on the stock in a research note on Tuesday, April 28th. Finally, Mizuho set a $17.00 target price on Herbalife in a research note on Monday, May 4th. Three analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Herbalife presently has an average rating of “Hold” and an average price target of $17.80.
Check Out Our Latest Stock Analysis on Herbalife
Herbalife Company Profile
Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.
Founded in 1980 by Mark R.
Featured Stories
- Five stocks we like better than Herbalife
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.
